RE: Dividend payments4 Dec 2020 13:07
To be honest, there are tell tale signs the paraytec test will not happen. They have already waited for a couple of months for clinical trials and heard nothing as of yet. Funding allocation to paraytec has been cut from £3.1m to £2.6m. however, the most important thing is the efficacy rate which Carl said if at 95% , they would stop doing the test .
I never in a million years saw the share dividend coming to £15m to shareholders, but I'm pretty sure the paraytec covid test is in limbo. This is probably a good thing as they can focus on other cancer tests through light photon detection.
Just saying as it is as most long term holders know me for being a no b.s guy. Hopefully we are gonna see 60p very soon